Development and Characterization of a Dual Nanofibrillar Membrane of Polylactic Acid Loaded with Hydroxyapatite and Chlorhexidine for Guided Bone Regeneration
Abstract
Guided bone regeneration requires membranes that combine structural stability, biocompatibility, and bioactive properties. This study aimed to develop a bilayer electrospun polylactic acid (PLA) membrane incorporating nanohydroxyapatite (nano-HA) and chlorhexidine (CHX). Membranes were fabricated by electrospinning at 15 kV and divided into four groups: PLA 10% (control), PLA 10%/CHX 0.2%, PLA 10%/nano-HA 10%, and a bilayer combining the CHX- and nano-HA-loaded formulations in separate monolayers, creating a bilayer nanofibrillar scaffold. We characterized microscopic structure, thermal behavior, and chemical composition using scanning electron microscopy, differential scanning calorimetry, thermogravimetric analysis, Fourier-transform infrared spectroscopy, and energy-dispersive X-ray spectroscopy. We evaluated cellular compatibility through cell adhesion and WST-1 metabolic activity assays. All groups exhibited randomly arranged nanofibrillar networks with comparable fiber morphology, while nano-HA-containing membranes showed particulate agglomerates. Thermal analyses indicated changes associated with material incorporation without evidence of major disruption of the PLA matrix, while chemical analyses confirmed incorporation of nano-HA and CHX. CHX-containing membranes did not compromise cell viability, whereas HA-containing membranes promoted favorable cell distribution and morphology. These findings demonstrate the feasibility of producing bilayer PLA membranes…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.